Logo

Nonacus Whole-Genome Sequencing Service for SARS-CoV-2 Testing Laboratories

Mar 12, 2021

Nonacus, based in Birmingham, UK, has launched a new service for whole-genome sequencing of SARS-CoV-2, developed under a grant from Innovate UK to support the UK government's test-to-release scheme. All international arrivals to the UK are required to take a test on days two and eight of their quarantine period for variant surveillance. Day-two samples shown to be positive from qRT-PCR testing will have the SARS-CoV-2 genomes sequenced to look for novel variants. Nonacus' new service will support this scheme and enable monitoring of the disease, the company said.

Breaking News
The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.